Immunological impacts and clinical implications of cigarette smoking on blood cell CD marker regulation: A comprehensive review article

نویسندگان
doi
10.48309/jmpcr.2026.563397.1919
چکیده

Cigarette smoking alters the immune system in a wide range of ways, including changes in circulating leukocyte populations and the expression of certain cell-surface clusters of differentiation markers. These perturbations impact innate immune cells (neutrophils, monocytes/macrophages, NK cells), adaptive lymphocytes (T and B cells), circulating progenitor/stem cells (CD34⁺), erythrocytes, and platelet CD markers, and have functional implications for host defense, inflammation, tissue repair, and cancer surveillance. This review summarizes human and translational evidence on which CD markers and cell subsets are most consistently altered by active cigarette smoking, investigates proposed mechanisms (oxidative stress, receptor modulation, bone marrow niche effects, and microbial translocation), and discusses clinical and methodological considerations. The primary evidence is drawn from studies utilizing flow cytometry to assess CD markers in peripheral blood. Where relevant, these phenotypic changes are integrated with discussions of associated functional alterations ( e.g., eryptosis and platelet aggregation), mechanistic insights, and clinical implications.